September 16, 2021
RegMed Investors’ (RMi) pre-open: exit early, meaning today
September 15, 2021
RegMed Investors’ (RMi) pre-open: after six (6) negative of the last ten (10) sessions – a few buy maybes but, be cautionary and selective in moves
September 1, 2021
RegMed Investors’ (RMi) pre-open: A risk-on environment although sentiment remains weak, following in the market not leading for the sector
August 26, 2021
RegMed Investors’ (RMi) pre-open: low volume and percentage moves to the upside within another record high
August 25, 2021
RegMed Investors’ (RMi) pre-open: remember the mantra, new market and sector highs and I usually say bye but, there are a few “moves” out there
August 24, 2021
RegMed Investors’ (RMi) pre-open: skim the upside moves while one can
August 23, 2021
RegMed Investors’ (RMi) pre-open: market gained after loses while sector gained; what’s next?
August 16, 2021
RegMed Investors’ (RMi) closing bell: starting the week, the cell and gene therapy sector exhibits an irregular pulse and heartbeat
July 1, 2021
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector bounces after Wednesday’s slight slippage
June 30, 2021
RegMed Investors’ (RMi) pre-open: last trading day of 1st half, June and Q2
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.